fashion -WSS

fashion

author：focus 2025-09-29 20:52:41 - browse：65561

a liver made up by geometric shapes – biotech coverage from STAT — Adobe

LONDON — A drug in development as a weight loss treatment succeeded in a Phase 2 study in a serious liver condition, its developers said Monday, as the competition in the broader obesity medicine field pushes ahead.

The drug, survodutide, is being developed by the privately held German firm Boehringer Ingelheim and the Danish biotech Zealand Pharma. Zealand’s share price has doubled over the past year over the potential of the drug, and on Monday morning, shares jumped another 25%.

In the study, 83% of patients with a condition called MASH and who were treated with survodutide saw significant improvements in their disease compared to 18% of those who received placebo. The study met its primary endpoint of improvements in MASH after 48 weeks without the worsening of fibrosis, a scarring of the liver, the companies said. Secondary endpoints were also met, including an improvement in fibrosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban
Next article： FDA approves updated Covid vaccines

WSS

Diverse clinical trials: Why aren’t we there yet?

'Insanity': 4th of July mass shootings across US kill 13, injure more than 80

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

FDA panel endorses Alnylam’s heart drug — after picking it apart

Food makers tried to stack nutrition panel with preferred experts

The leaders of Italy and Poland say European Union should focus on stopping migration

Wikipedia

fashion

explore

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The leaders of Italy and Poland say European Union should focus on stopping migration

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

White House touts steps to stem shortages of cancer treatments

Trump demands the U.S. pay no more for drugs than other countries … again

EU moves toward latest gene techniques in food production to counter climate change, shortages

Moonlake's readout produced a cash windfall. Risks remain

FDA proposes changes to key medical devices approval pathway

Moonlake's readout produced a cash windfall. Risks remain

New Covid vaccine is recommended for everyone 6 months or older

focus

Telehealth for opioid use disorder is lifesaving

Acelyrin, a rare IPO success, stumbles in its first big test

Private equity could exacerbate cardiology's overuse problem, experts fear

WATCH: Why do bright lights make us see spots?

5 shark bites reported on Long Island as officials deploy surveillance drones

Pig kidney works a record two months in donated body

entertainment

knowledge

knowledge

entertainment